Skip Nav Destination
Issues
1 June 2009
-
Cover Image
Cover Image
Expression of DNA methyltransferase-3B (DNMT3B) in human colon cancer. Among 765 colorectal cancers, DNMT3B expression was associated with CpG island methylator phenotype (CIMP)-high, suggesting that DNMT3B contributes to CIMP-high in colorectal cancer. For further details, please see the article by Nosho and colleagues on page 3663 of this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
CCR Translations
Molecular Pathways
Human Cancer Biology
Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer
Roshan Agarwal; Ana-Maria Gonzalez-Angulo; Simen Myhre; Mark Carey; Ju-Seog Lee; Jens Overgaard; Jan Alsner; Katherine Stemke-Hale; Ana Lluch; Richard M. Neve; Wen Lin Kuo; Therese Sorlie; Aysegul Sahin; Vicente Valero; Khandan Keyomarsi; Joe W. Gray; Anne-Lise Borresen-Dale; Gordon B. Mills; Bryan T. Hennessy
DNMT3B Expression Might Contribute to CpG Island Methylator Phenotype in Colorectal Cancer
Katsuhiko Nosho; Kaori Shima; Natsumi Irahara; Shoko Kure; Yoshifumi Baba; Gregory J. Kirkner; Li Chen; Sumita Gokhale; Aditi Hazra; Donna Spiegelman; Edward L. Giovannucci; Rudolf Jaenisch; Charles S. Fuchs; Shuji Ogino
Cancer Therapy: Preclinical
Molecular Mechanisms Underlying Effects of Epidermal Growth Factor Receptor Inhibition on Invasion, Proliferation, and Angiogenesis in Experimental Glioma
Jean-Sébastien Guillamo; Sophie de Boüard; Samuel Valable; Lena Marteau; Pascal Leuraud; Yannick Marie; Marie-France Poupon; Jean-Jacques Parienti; Eric Raymond; Marc Peschanski
Histone Deacetylase Inhibitors Induce a Very Broad, Pleiotropic Anticancer Drug Resistance Phenotype in Acute Myeloid Leukemia Cells by Modulation of Multiple ABC Transporter Genes
Stefanie Hauswald; Jesus Duque-Afonso; Michaela M. Wagner; Florian M. Schertl; Michael Lübbert; Christian Peschel; Ulrich Keller; Thomas Licht
HGF and c-Met Participate in Paracrine Tumorigenic Pathways in Head and Neck Squamous Cell Cancer
Lynn M. Knowles; Laura P. Stabile; Ann Marie Egloff; Mary E. Rothstein; Sufi M. Thomas; Christopher T. Gubish; Edwina C. Lerner; Raja R. Seethala; Shinsuke Suzuki; Kelly M. Quesnelle; Sarah Morgan; Robert L. Ferris; Jennifer R. Grandis; Jill M. Siegfried
Therapeutic Targeting of ATP7B in Ovarian Carcinoma
Lingegowda S. Mangala; Vesna Zuzel; Rosemarie Schmandt; Erik S. Leshane; Jyotsna B. Halder; Guillermo N. Armaiz-Pena; Whitney A. Spannuth; Takemi Tanaka; Mian M.K. Shahzad; Yvonne G. Lin; Alpa M. Nick; Christopher G. Danes; Jeong-Won Lee; Nicholas B. Jennings; Pablo E. Vivas-Mejia; Judith K. Wolf; Robert L. Coleman; Zahid H. Siddik; Gabriel Lopez-Berestein; Svetlana Lutsenko; Anil K. Sood
Imaging, Diagnosis, Prognosis
Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene
Peter Brader; Kaitlyn J. Kelly; Nanhai Chen; Yong A. Yu; Qian Zhang; Pat Zanzonico; Eva M. Burnazi; Rashid E. Ghani; Inna Serganova; Hedvig Hricak; Aladar A. Szalay; Yuman Fong; Ronald G. Blasberg
Serum Peptidome Profiling Revealed Platelet Factor 4 as a Potential Discriminating Peptide Associated with Pancreatic Cancer
Georg Martin Fiedler; Alexander Benedikt Leichtle; Julia Kase; Sven Baumann; Uta Ceglarek; Klaus Felix; Tim Conrad; Helmut Witzigmann; Arved Weimann; Christof Schütte; Johann Hauss; Markus Büchler; Joachim Thiery
Proteasome Enzymatic Activities in Plasma as Risk Stratification of Patients with Acute Myeloid Leukemia and Advanced-Stage Myelodysplastic Syndrome
Wanlong Ma; Hagop Kantarjian; Benjamin Bekele; Amber C. Donahue; Xi Zhang; Zhong J. Zhang; Susan O'Brien; Elihu Estey; Zeev Estrov; Jorge Cortes; Michael Keating; Francis Giles; Maher Albitar
Tumoral Expression of TXR1 and TSP1 Predicts Overall Survival of Patients with Lung Adenocarcinoma Treated with First-line Docetaxel-Gemcitabine Regimen
Chara Papadaki; Dimitris Mavroudis; Maria Trypaki; Anastasios Koutsopoulos; Efstathios Stathopoulos; Dora Hatzidaki; Eleftheria Tsakalaki; Vassilis Georgoulias; John Souglakos
Cancer Therapy: Clinical
Quality of Reporting of Serious Adverse Drug Events to an Institutional Review Board: A Case Study with the Novel Cancer Agent, Imatinib Mesylate
David A. Dorr; Rachel Burdon; Dennis P. West; Jennifer Lagman; Christina Georgopoulos; Steven M. Belknap; June M. McKoy; Benjamin Djulbegovic; Beatrice J. Edwards; Sigmund A. Weitzman; Simone Boyle; Martin S. Tallman; Moshe Talpaz; Oliver Sartor; Charles L. Bennett
Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision
Cheryl A. London; Phyllis B. Malpas; Stacey L. Wood-Follis; Joseph F. Boucher; Anthony W. Rusk; Mona P. Rosenberg; Carolyn J. Henry; Kathy L. Mitchener; Mary K. Klein; John G. Hintermeister; Philip J. Bergman; Guillermo C. Couto; Guy N. Mauldin; Gina M. Michels
Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors
Taroh Satoh; Isamu Okamoto; Masaki Miyazaki; Ryotaroh Morinaga; Asuka Tsuya; Yoshikazu Hasegawa; Masaaki Terashima; Shinya Ueda; Masahiro Fukuoka; Yutaka Ariyoshi; Toshikazu Saito; Noriyuki Masuda; Hirokazu Watanabe; Tetsuo Taguchi; Toru Kakihara; Yumiko Aoyama; Yohko Hashimoto; Kazuhiko Nakagawa
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.